Molly Henderson's Net Worth

$1.03 Million

Estimate Recalculated Jun 11, 2024 12:17PM EST

Who is Molly Henderson?

Molly Henderson has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include Phathom Pharmaceuticals, Inc., Lion Biotechnologies, Inc., UroGen Pharma Ltd., Advaxis, Inc., and VirtualScopics, Inc..

SEC CIK

Molly Henderson's CIK is 0001363812

Past Insider Trading and Trends

2022 was Molly Henderson's most active year for acquiring shares with 8 total transactions. Molly Henderson's most active month to acquire stocks was the month of December. 2023 was Molly Henderson's most active year for disposing of shares, totalling 7 transactions. Molly Henderson's most active month to dispose stocks was the month of October. 2021 saw Molly Henderson paying a total of $39,625.00 for 30,500 shares, this is the most they've acquired in one year. In 2023 Molly Henderson cashed out on 24,160 shares for a total of $218,142.44, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.025

CFO and CBO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+7.87%
7.5K
102.76K
May 31
Form 4
-3.48%
-3.44K
$11.10
-$38,128.50
95.26K
Apr 8
Form 4
-6.01%
-6.31K
$7.75
-$48,900.06
98.7K
Jan 18 - Jan 19
Form 4
-2.02%
-2.13K
$7.24
-$15,402.67
103.06K
Nov 20
Form 4
+10.51%
10.01K
$8.88
-$110,870.75
105.19K
Nov 1
Form 4/A
+35.62%
25K
95.18K
Jul 14
Form 4
+35.62%
25K
$1.00
$25,000.00
95.18K
Jul 14
Form 4
-2.78%
-1.96K
$11.41
-$22,367.72
68.51K
Jun 2
Form 4
-2.91%
-2.11K
$12.87
-$27,164.98
70.47K
May 22
Form 4
-4.52%
-3.44K
$7.27
-$25,001.53
72.58K
Apr 6
Form 4
-2.60%
-2.03K
$8.53
-$17,334.79
76.02K
Scheduled
Mar 1
Form 4
+73.26%
33K
78.05K
Jan 19
Form 4
-4.75%
-2.16K
$9.60
-$20,726.40
43.34K
Nov 21
Form 4
+19.74%
7.5K
45.5K
Sep 1
Form 4
+46.15%
12K
38K
May 19
Form 4
+30.00%
6K
26K
May 13
Form 4
20K
20K
Apr 5
Form 3
0
0
No matching records found

Lion Biotechnologies, Inc. (IOVA) Snapshot price: $8.15

CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 1 - Jun 10
Form 4
0
0
Mar 11
Form 4
0
0
Dec 28
Form 4
0
0
Jun 8
Form 3
0
0
No matching records found

UroGen Pharma Ltd. (URGN) Snapshot price: $15.76

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.82%
335
$7.58
-$2,508.98
5.25K
Jan 31
Form 4
+96.52%
2.41K
$12.03
-$31,121.61
4.91K
Nov 30
Form 4
0
0
Jun 5
Form 4
2.5K
$15.85
$39,625.00
2.5K
May 17
Form 4
0
0
Jan 31
Form 4
0
0
Oct 1
Form 3
0
0
No matching records found

Advaxis, Inc. (ADXS) Snapshot price: $1.12

Executive Vice President & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 4
Form 4
0
0
Oct 24
Form 4
+75.01%
2.5K
$3.68
$9,199.75
5.83K
Apr 11
Form 4
3K
$3.86
$11,578.71
3K
Apr 9
Form 4
0
0
Nov 5
Form 4
5K
$1.89
$9,450.00
5K
Jun 12
Form 4
0
0
Jun 6
Form 3
0
0
No matching records found

VirtualScopics, Inc. No price found

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
Form 3
0
0
No matching records found